Index of artpub/2018/pmc_30328061/

Salavert, Miguel
Cost-Effectiveness Analysis of Bezlotoxumab Added to Standard of Care Versus Standard of Care Alone for the Prevention of Recurrent Clostridium difficile Infection in High-Risk Patients in Spain
2018
https://ddd.uab.cat/record/228046